FDA Commissioner Robert Califf highlighted the concerning trend of deteriorating health outcomes in the U.S., particularly in relation to chronic diseases like type 2 diabetes. While advancements in technology and innovation are abundant, they have not translated into better health for the population. Califf emphasized the need for more research on bariatric surgery and the underutilized potential of obesity drugs in treating various conditions. He also stressed the importance of conducting trials to determine the benefits and risks of these treatments. Additionally, Califf discussed the disparities in access to digital health tools and the need for more inclusive approaches to improve overall health outcomes.
Source link
With type 2 diabetes, ‘we’re failing right now,’ FDA chief says
